NO992500L - 2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister - Google Patents

2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister

Info

Publication number: NO992500L
Authority: NO; Norway
Prior art keywords: imidazolinylaminobenzoxazole; alfa; compounds useful; adrenoceptor agonists; adrenoceptor
Prior art date: 1996-11-25

Application number

NO992500A

Other languages

English (en)

Other versions

NO313755B1 (no

NO992500D0 (no

Inventor

Raymond Todd Henry

Russell James Sheldon

William Lee Seibel

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-25

Filing date

1999-05-25

Publication date

1999-07-26

1999-05-25 Application filed by Procter & Gamble filed Critical Procter & Gamble

1999-05-25 Publication of NO992500D0 publication Critical patent/NO992500D0/no

1999-07-26 Publication of NO992500L publication Critical patent/NO992500L/no

2002-11-25 Publication of NO313755B1 publication Critical patent/NO313755B1/no

Links

108060003345 Adrenergic Receptor Proteins 0.000 title 1
102000017910 Adrenergic receptor Human genes 0.000 title 1
239000000556 agonist Substances 0.000 title 1
WWGDPXQOBQLMRI-UHFFFAOYSA-N n-(4,5-dihydroimidazol-1-yl)-1,3-benzoxazol-2-amine Chemical class C1=NCCN1NC1=NC2=CC=CC=C2O1 WWGDPXQOBQLMRI-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

NO19992500A 1996-11-25 1999-05-25 2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister NO313755B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3178796P	1996-11-25	1996-11-25
PCT/US1997/020803 WO1998023611A1 (en)	1996-11-25	1997-11-21	2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists

Publications (3)

Publication Number	Publication Date
NO992500D0 NO992500D0 (no)	1999-05-25
NO992500L true NO992500L (no)	1999-07-26
NO313755B1 NO313755B1 (no)	2002-11-25

Family

ID=21861392

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19992500A NO313755B1 (no)	1996-11-25	1999-05-25	2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister

Country Status (18)

Country	Link
US (1)	US6110952A (no)
EP (1)	EP0944622A1 (no)
JP (1)	JP2001506601A (no)
KR (1)	KR20000069128A (no)
AU (1)	AU736992B2 (no)
BR (1)	BR9713537A (no)
CA (1)	CA2272683A1 (no)
CO (1)	CO4910150A1 (no)
CZ (1)	CZ183699A3 (no)
HU (1)	HUP0002966A3 (no)
ID (1)	ID22060A (no)
IL (1)	IL130094A (no)
NO (1)	NO313755B1 (no)
PE (1)	PE16599A1 (no)
SK (1)	SK74999A3 (no)
TR (1)	TR199901486T2 (no)
WO (1)	WO1998023611A1 (no)
ZA (1)	ZA9710579B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6110952A (en) *	1996-11-25	2000-08-29	The Procter & Gamble Company	2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
WO2000051625A1 (en) *	1999-03-05	2000-09-08	The Trustees Of University Technology Corporation	Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
EP2402323A3 (en) *	2004-10-13	2012-05-30	PTC Therapeutics, Inc.	Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
JP2009514969A (ja)	2005-11-09	2009-04-09	コンビナトアールエックスインコーポレーティッド	医学的状態を治療するための方法、組成物、およびキット
US12246013B2 (en)	2008-08-01	2025-03-11	Eye Therapies Llc	Vasoconstriction compositions and methods of use
US20100197694A1 (en) *	2008-08-01	2010-08-05	Gerald Horn	Compositions and methods for treatment of diseases and conditions with increased vascular permeability
US20100203165A1 (en)	2008-08-01	2010-08-12	Gerald Horn	Compositions and methods for treatment of disorders or conditions of the eye
US20100202979A1 (en) *	2008-08-01	2010-08-12	Gerald Horn	Compositions and methods for treatment of pulmonary diseases and conditions
HRP20141047T1 (hr) *	2008-08-01	2015-01-02	Eye Therapies Llc	Pripravci za sužavanje krvnih žila i metode njihove uporabe
US20110003823A1 (en) *	2008-08-01	2011-01-06	Alpha Synergy Development, Inc.	Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
US8952011B2 (en)	2008-08-01	2015-02-10	Eye Therapies Llc	Compositions and methods for the treatment of nasal conditions
US8555875B2 (en)	2008-12-23	2013-10-15	Map Pharmaceuticals, Inc.	Inhalation devices and related methods for administration of sedative hypnotic compounds
US8987270B2 (en)	2009-07-27	2015-03-24	Eye Therapies Llc	Formulations of selective alpha-2 agonists and methods of use thereof
RU2014106367A (ru) *	2011-07-25	2015-08-27	Аллерган, Инк.	N-(ИМИДАЗОЛИДИН-2-ИЛИДЕН)-ГЕТЕРОЦИКЛОПЕНТА[b]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ АЛЬФА 2 АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE795970A (fr) *	1972-02-29	1973-08-27	Pfizer	Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US3830804A (en) *	1972-11-20	1974-08-20	Eastman Kodak Co	Fluorescent(pyrimidinotriazolyl)-2-styrylbenzoxazoles
US4398028A (en) *	1977-01-14	1983-08-09	Sandoz Ltd.	Bicyclic heterocyclic amino derivatives
FR2521140A1 (fr) *	1982-02-05	1983-08-12	Synthelabo	Derives d'imidazolidine, leur preparation et leur application en therapeutique
US5091528A (en) *	1990-09-12	1992-02-25	Allergan, Inc.	6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
GB9110017D0 (en) *	1991-05-09	1991-07-03	Nat Res Dev	Spectroscopic investigation using organometallic compounds
JP3805360B2 (ja) *	1994-01-24	2006-08-02	アラーガン、インコーポレイテッド	α▲下２Ａ▼アドレナリン受容体作動剤としての芳香族２−アミノ−イミダゾール誘導体
CA2196792A1 (en) *	1994-08-04	1996-02-15	Yoon T. Jeon	Novel benzimidazole derivatives
KR100215541B1 (ko) *	1996-04-19	1999-08-16	박원훈	벤족사졸계 비선형 광학 유도체 및 이들로부터 얻어진고분자
US6110952A (en) *	1996-11-25	2000-08-29	The Procter & Gamble Company	2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists

1997
- 1997-11-21 US US09/308,792 patent/US6110952A/en not_active Expired - Fee Related
- 1997-11-21 KR KR1019997004616A patent/KR20000069128A/ko not_active Ceased
- 1997-11-21 CA CA002272683A patent/CA2272683A1/en not_active Abandoned
- 1997-11-21 CZ CZ991836A patent/CZ183699A3/cs unknown
- 1997-11-21 AU AU54382/98A patent/AU736992B2/en not_active Ceased
- 1997-11-21 TR TR1999/01486T patent/TR199901486T2/xx unknown
- 1997-11-21 EP EP97948291A patent/EP0944622A1/en not_active Withdrawn
- 1997-11-21 WO PCT/US1997/020803 patent/WO1998023611A1/en not_active Ceased
- 1997-11-21 SK SK749-99A patent/SK74999A3/sk unknown
- 1997-11-21 IL IL13009497A patent/IL130094A/en not_active IP Right Cessation
- 1997-11-21 HU HU0002966A patent/HUP0002966A3/hu unknown
- 1997-11-21 JP JP52469598A patent/JP2001506601A/ja active Pending
- 1997-11-21 BR BR9713537A patent/BR9713537A/pt not_active Application Discontinuation
- 1997-11-21 ID IDW990411A patent/ID22060A/id unknown
- 1997-11-24 CO CO97068611A patent/CO4910150A1/es unknown
- 1997-11-25 ZA ZA9710579A patent/ZA9710579B/xx unknown
- 1997-11-25 PE PE1997001065A patent/PE16599A1/es not_active Application Discontinuation
1999
- 1999-05-25 NO NO19992500A patent/NO313755B1/no unknown

Also Published As

Publication number	Publication date
IL130094A0 (en)	2000-02-29
BR9713537A (pt)	2000-03-21
HUP0002966A2 (hu)	2001-09-28
HUP0002966A3 (en)	2001-10-29
JP2001506601A (ja)	2001-05-22
CO4910150A1 (es)	2000-04-24
ID22060A (id)	1999-08-26
CA2272683A1 (en)	1998-06-04
WO1998023611A1 (en)	1998-06-04
TR199901486T2 (xx)	1999-10-21
ZA9710579B (en)	1998-06-25
AU5438298A (en)	1998-06-22
US6110952A (en)	2000-08-29
EP0944622A1 (en)	1999-09-29
IL130094A (en)	2001-09-13
NO313755B1 (no)	2002-11-25
NO992500D0 (no)	1999-05-25
PE16599A1 (es)	1999-03-12
AU736992B2 (en)	2001-08-09
CZ183699A3 (cs)	1999-09-15
SK74999A3 (en)	2000-02-14
KR20000069128A (ko)	2000-11-25

Publication	Publication Date	Title
NO992470L (no)	1999-07-26	2-amidazolinyl-amino-indolforbindelser anvendelige som <alfa>-2-adreno-reseptoragonister
NO992498L (no)	1999-07-26	Guanidinylheterocykelforbindelser anvendelige som <alfa>-2 adrenoceptoragonister
FI954738L (fi)	1995-12-05	Tetrasykliini yhdisteet dopamiiniagonisteina
DE69733506D1 (de)	2005-07-21	Schmierende Zusammensetzung
BR9509760A (pt)	1998-06-30	Composto
DE69915289D1 (de)	2004-04-08	Kühlvorrichtung
NO992500D0 (no)	1999-05-25	2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister
DK0975623T3 (da)	2002-10-14	Indazolamidforbindelser som sertoninerge midler
DE69936208D1 (de)	2007-07-12	Modifiziermittel enthaltende zusammensetzung
ITRM940002A0 (it)	1994-01-05	Composizione orale.
DE69700310D1 (de)	1999-08-12	Rostschutzzusammensetzung
DE69907643D1 (de)	2003-06-12	Schmiermittelzusammensetzung
NO983594D0 (no)	1998-08-05	Heterosykliske tioetere som additiver for smöremidler
NO20012526L (no)	2001-05-23	Sammensetninger som innbefatter cefuroksimaksetil
NO20013013D0 (no)	2001-06-18	<alfa>v<beta>6-integrininhibitorer
DE59910800D1 (de)	2004-11-18	Kühler
NO992502D0 (no)	1999-05-25	2-Imidazolinylaminoindazolforbindelser nyttige som <alfa>-2 adrenerge reseptoragonister
NO992503L (no)	1999-07-23	Guanidinylamino heterocykelforbindelser nyttige som <alfa>-2 adrenerge reseptoragonister
NO995030D0 (no)	1999-10-15	5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister
DE69934143D1 (de)	2007-01-04	Acrylkautschukmischung
IT1275802B1 (it)	1997-10-17	Composizione di interferone
NO20010280L (no)	2001-03-08	<Alfa>-aminosyrefenylesterderivater
FIU980429U0 (fi)	1998-10-02	Voiteluainekoostumus
ITTO940841A0 (it)	1994-10-20	Lampada per uso domestico, utilizzabile anche come lampada di emergen-za ad intervento automatico
SE9801397D0 (sv)	1998-04-21	Novel compounds